AJCN North Carolina Research Campus
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Donahue, S. P.
Right arrow Articles by Phillips, L. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Donahue, S. P.
Right arrow Articles by Phillips, L. S.
Agricola
Right arrow Articles by Donahue, S. P.
Right arrow Articles by Phillips, L. S.

American Journal of Clinical Nutrition, Vol 50, 962-969, Copyright © 1989 by The American Society for Clinical Nutrition, Inc


ORIGINAL RESEARCH COMMUNICATIONS

Response of IGF-1 to nutritional support in malnourished hospital patients: a possible indicator of short-term changes in nutritional status

SP Donahue and LS Phillips
Department of Medicine, Emory University School of Medicine, Atlanta, GA 30303.

IGF-1 is a circulating growth factor with hepatic release dependent on nutritional status. To determine if IGF-1 could be a useful nutritional index, 15 malnourished patients were assessed during nutritional support. Patients with protein or protein-calorie malnutrition had lower IGF-1 (39 +/- 7 micrograms/L) than did patients with calorie-only malnutrition (109 +/- 25 micrograms/L, p less than 0.005); transferrin concentrations did not differ between the two groups. Nutritional supplementation produced an increase in IGF-1 (123 +/- 32 micrograms/L, p less than 0.005); the relative increase in IGF-1 (264 +/- 62%, p less than 0.001) exceeded increases in albumin or transferrin (9 +/- 6% and 59 +/- 16%, NS and p less than 0.005, respectively). Reduction or termination of support was followed by a decrease in IGF-1 to 59 +/- 9% of peak values (p less than 0.001) but neither albumin nor transferrin decreased significantly. Changes in IGF-1 were correlated with nitrogen balance (r = 0.45, p less than 0.005). The strong relationship between IGF-1 and nutritional status suggests that IGF-1 determinations may be useful in guiding nutritional therapy in patients whose nitrogen balance is difficult to assess.


This article has been cited by other articles:


Home page
Endocr. Rev.Home page
A. Giustina, G. Mazziotti, and E. Canalis
Growth Hormone, Insulin-Like Growth Factors, and the Skeleton
Endocr. Rev., August 1, 2008; 29(5): 535 - 559.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
T. L. Ballard, J. A Clapper, B. L Specker, T. L Binkley, and M. D Vukovich
Effect of protein supplementation during a 6-mo strength and conditioning program on insulin-like growth factor I and markers of bone turnover in young adults
Am. J. Clinical Nutrition, June 1, 2005; 81(6): 1442 - 1448.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
I Sermet-Gaudelus, J C Souberbielle, I Azhar, J C Ruiz, P Magnine, V Colomb, C Le Bihan, D Folio, and G Lenoir
Insulin-like growth factor I correlates with lean body mass in cystic fibrosis patients
Arch. Dis. Child., November 1, 2003; 88(11): 956 - 961.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
K. R. Kritsch, S. Murali, M. L. Adamo, and D. M. Ney
Dexamethasone decreases serum and liver IGF-I and maintains liver IGF-I mRNA in parenterally fed rats
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2002; 282(2): R528 - R536.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Hotta, I. Fukuda, K. Sato, N. Hizuka, T. Shibasaki, and K. Takano
The Relationship between Bone Turnover and Body Weight, Serum Insulin-Like Growth Factor (IGF) I, and Serum IGF-Binding Protein Levels in Patients with Anorexia Nervosa
J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 200 - 206.
[Abstract] [Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
G. GAYAN-RAMIREZ, F. VANDERHOYDONC, G. VERHOEVEN, and M. DECRAMER
Acute Treatment with Corticosteroids Decreases IGF-1 and IGF-2 Expression in the Rat Diaphragm and Gastrocnemius
Am. J. Respir. Crit. Care Med., January 1, 1999; 159(1): 283 - 289.
[Abstract] [Full Text]


Home page
J. Nutr.Home page
L. E. Underwood
Special Considerations in the Design of Trials Involving Children
J. Nutr., January 1, 1999; 129(1): 264S - 264S.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
W. J. Smith, L. E. Underwood, L. Keyes, and D. R. Clemmons
Use of Insulin-Like Growth Factor I (IGF-I) and IGF-Binding Protein Measurements to Monitor Feeding of Premature Infants
J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 3982 - 3988.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1989 by The American Society for Nutrition